Peristomal infection after percutaneous endoscopic gastrostomy: a 7-year surveillance of 297 patients
- PMID: 23329219
- DOI: 10.1590/s0004-28032012000400005
Peristomal infection after percutaneous endoscopic gastrostomy: a 7-year surveillance of 297 patients
Abstract
Context: Healthcare-associated infection represents the most frequent adverse event during care delivery. Medical advances like percutaneous endoscopic gastrostomy have brought improvement on quality of life to patients but an increased risk of healthcare-associated infection. Predictive risk factors for peristomal wound infection are largely unknown but evidence suggests that antibiotic prophylaxis and preventive strategies related to infection control may reduce infection rates.
Objectives: The primary aim was to evaluate the global prevalence rate of peristomal infection. Secondary objectives were to characterise the positive culture results, to evaluate the prophylactic antibiotic protocol and to identify potential risk factors for peristomal infection.
Methods: Retrospective study of 297 patients with percutaneous endoscopic gastrostomy performed at a general hospital between January 2004 and September 2010. Patients received prophylactic cefazolin before the endoscopic gastrostomy procedure. Medical records were reviewed for demographic data, underling disease conditions to percutaneous endoscopic gastrostomy and patient potential intrinsic risk factors. Statistical analysis was made with the statistical program SPSS 17.0.
Results: A total of 297 percutaneous endoscopic gastrostomy tubes were inserted. Wound infection occurred in 36 patients (12.1%). Staphylococcus aureus methicillin resistant was the most frequently isolated microorganism (33.3%) followed by Pseudomonas aeruginosa (30.6%). The incidence rate had been rising each year and differ from 4.65% in 2004/2007 to 17.9% in 2008/2010. This finding was consistent with the increasing of prevalence global infection rates of the hospital. Most of the infections (55.6%) were detected in the first 10 days post procedure. There was no significant difference in age, body mass index values, mean survival time and duration of percutaneous endoscopic gastrostomy feeding between patients with and without periostomal infection. Institutional factors, namely global prevalence infection rates and the endemic character of Staphylococcus aureus methicillin resistant, play an important role in peristomal infection rates. Traditional antibiotic prophylaxis with cefazolin is not adequate due to the prevalence of resistant organisms.
Conclusions: Peristomal infection is a frequent problem with clinical impact in percutaneous endoscopic gastrostomy patients and should be considered a healthcare associated infection. The antimicrobial prophylaxis regimens using cephalosporins are not adequate and need to be reviewed due to the high prevalence of Staphylococcus aureus methicillin resistant and other resistant organisms in hospitals and nursing homes.
Similar articles
-
Percutaneous endoscopic gastrostomy site infections-Incidence and risk factors.Indian J Gastroenterol. 2018 Mar;37(2):103-107. doi: 10.1007/s12664-018-0822-4. Epub 2018 Feb 23. Indian J Gastroenterol. 2018. PMID: 29473130
-
Antibiotic prophylaxis in percutaneous endoscopic gastrostomy.Am J Gastroenterol. 1996 Nov;91(11):2301-4. Am J Gastroenterol. 1996. PMID: 8931406 Clinical Trial.
-
The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus.Aliment Pharmacol Ther. 2007 Mar 1;25(5):593-7. doi: 10.1111/j.1365-2036.2006.03242.x. Aliment Pharmacol Ther. 2007. PMID: 17305760
-
Percutaneous feeding gastrostomy.Med J Aust. 1989 Sep 18;151(6):328, 330-1. doi: 10.5694/j.1326-5377.1989.tb128471.x. Med J Aust. 1989. PMID: 2512472 Review.
-
The changing face of Staphylococcus aureus: a continuing surgical challenge.Surg Infect (Larchmt). 2011 Jun;12(3):191-203. doi: 10.1089/sur.2011.068. Surg Infect (Larchmt). 2011. PMID: 21812657 Review.
Cited by
-
Percutaneous endoscopic gastrostomy (PEG) site infections: a clinical and microbiological study from university teaching hospital, India.J Infect Prev. 2015 May;16(3):113-116. doi: 10.1177/1757177414558956. Epub 2014 Dec 10. J Infect Prev. 2015. PMID: 28989413 Free PMC article.
-
Mixed Fungal Biofilms: From Mycobiota to Devices, a New Challenge on Clinical Practice.Microorganisms. 2022 Aug 26;10(9):1721. doi: 10.3390/microorganisms10091721. Microorganisms. 2022. PMID: 36144323 Free PMC article. Review.
-
Percutaneous endoscopic gastrostomy site infections-Incidence and risk factors.Indian J Gastroenterol. 2018 Mar;37(2):103-107. doi: 10.1007/s12664-018-0822-4. Epub 2018 Feb 23. Indian J Gastroenterol. 2018. PMID: 29473130
-
Prevention and management of minor complications in percutaneous endoscopic gastrostomy.BMJ Open Gastroenterol. 2022 Jul;9(1):e000975. doi: 10.1136/bmjgast-2022-000975. BMJ Open Gastroenterol. 2022. PMID: 35851280 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources